Conway Capital Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-650
Closed -$212K 47
2024
Q1
$212K Buy
+650
New +$160K 0.12% 44
2023
Q3
Sell
-1,760
Closed -$502K 46
2023
Q2
$502K Buy
1,760
+490
+39% +$136K 0.35% 29
2023
Q1
$275K Buy
1,270
+150
+13% +$29.2K 0.23% 37
2022
Q4
$230K Sell
1,120
-965
-46% -$244K 0.23% 42
2022
Q3
$580K Buy
+2,085
New +$530K 0.52% 29
2022
Q1
Sell
-1,585
Closed -$283K 71
2021
Q4
$283K Sell
1,585
-1,435
-48% -$283K 0.17% 49
2021
Q3
$622K Buy
3,020
+1,310
+77% +$257K 0.42% 38
2021
Q2
$324K Buy
+1,710
New +$280K 0.22% 51

Other funds holding SWAV

Conway Capital Management's SWAV Position: Q2 2024 in Review

Conway Capital Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 650 shares — an estimated $212K sold.

Conway Capital Management first reported a position in SWAV in Q2 2021 and held it in 8 quarters. The position peaked at $622K in Q3 2021. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Conway Capital Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Conway Capital Management sold 650 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $212K.
  • Conway Capital Management first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
  • Conway Capital Management's Shockwave Medical, Inc. Common Stock position peaked at $622K in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Conway Capital Management's 13F filing for Q2 2024, filed 3 Dec 2024.